拼接静脉导管在严重肢体威胁性缺血股-胫动脉旁路术中较人工血管具有更优的通畅性和保肢效果
基于美国国家外科质量改进计划数据库,比较拼接静脉与人工血管在严重肢体威胁性缺血股-胫动脉旁路术中的30天结局。倾向性评分匹配后,拼接静脉组30天一期通畅率显著优于人工血管组(87.5% vs 74.38%,P=0.004),手术时间更长、输血率更高,但未增加死亡或主要系统并发症。
要点
- 拼接静脉组30天一期通畅率显著高于人工血管组(87.5% vs 74.38%,P=0.004)。
- 拼接静脉组手术时间更长(346 min vs 222 min,P<0.001)、输血率更高(43.3% vs 27.87%,P=0.003)。
- 两组30天死亡、主要系统并发症、伤口并发症及肢体丢失无差异。
核心结论
- 拼接静脉导管较人工血管显著改善30天一期通畅率,且不增加死亡率和并发症发病率。
- 尽管手术更复杂、时间更长,作者认为有拼接静脉时应考虑使用。
- 作者指出需要未来前瞻性研究探究两种导管的长期结局。
研究设计与样本
- 回顾性队列研究,使用美国国家外科质量改进计划靶向数据库。
- 纳入仅使用拼接静脉或人工血管行下肢旁路术的严重肢体威胁性缺血患者。
- 共886例患者(拼接静脉104例,人工血管782例),按1:5倾向性评分匹配,拼接静脉组全部104例匹配至445例人工血管患者。
主要发现
- 拼接静脉组30天一期通畅率87.5% vs 人工血管组74.38%(P=0.004)。
- 拼接静脉组手术时间346 min vs 人工血管组222 min(P<0.001)。
- 拼接静脉组输血率43.3% vs 人工血管组27.87%(P=0.003)。
- 两组30天死亡率、主要系统并发症、伤口并发症及30天肢体丢失无差异。
临床怎么用
- 作者认为,尽管手术更复杂且手术时间更长,有拼接静脉时应考虑使用拼接静脉导管。
- 作者指出需要未来前瞻性研究探究两种导管的长期结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-segment great saphenous vein (ssGSV) is the gold standard conduit for femoral-tibial bypasses in patients with critical limb-threatening ischemia (CLTI). In the absence of a good single-segment saphenous vein, alternative options are prosthetic grafts or spliced-vein (SpV) conduits. Although SpV conduits may provide better long-term patency/limb salvage, prosthetic grafts are more often the chosen conduit due to shorter operative and presumably better immediate postoperative outcomes; nevertheless, there are little data supporting this practice. In this study, we compared 30-day outcomes between SpV and prosthetic conduits in CLTI bypass using a national registry. METHODS: CLTI patients who underwent lower extremity bypass using SpV or prosthetic conduits only were selected from the National Surgical Quality Improvement Program targeted database. A 1:5 propensity score matching was conducted between SpV and prosthetic groups to address preoperative differences. Thirty-day outcomes, including primary patency, reintervention, major amputation, mortality, major morbidity, transfusion, and wound complications, were compared between the 2 groups. RESULTS: There were 886 patients who underwent femoral-tibial bypass without ssGSV (104 SpV and 782 prosthetic grafts). All SpV patients were propensity score matched to 445 prosthetic patients. SpV exhibited significantly better 30-day primary patency than prosthetic (87.5% vs 74.38%, P = 0.004). SpV was associated with significantly longer operative time (346 min vs 222 min, P < 0.001) and higher transfusion (43.3% vs 27.87%, P = 0.003), but those did not translate into higher 30-day mortality or major systemic complications. There was no difference in wound complications or 30-day limb loss. CONCLUSIONS: SpV conduit affords significantly better 30-day primary patency than prosthetic grafts without increased mortality and morbidities. Therefore, despite greater procedural complexity and longer operative time, SpV conduit should be considered when available. Future prospective studies are needed to investigate the long-term outcomes of these 2 conduits.
引用
- Thompson J, Li R, Pomy BJ, et al. Spliced-Vein Conduit Offers Better Patency and Limb Salvage Than Prosthetic Graft for Femoral-Tibial Bypasses in Critical Limb-Threatening Ischemia. Ann Vasc Surg. 2024. PMID: 39341563. doi:10.1016/j.avsg.2024.07.118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。